Programmable protein circuits in living cells
US-10899823-B2 · Jan 26, 2021 · US
US11542305B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11542305-B2 |
| Application number | US-201916556063-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 29, 2019 |
| Priority date | Aug 31, 2018 |
| Publication date | Jan 3, 2023 |
| Grant date | Jan 3, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein include methods, compositions, and kits suitable for use in detecting the activation level of a signal transducer. In some embodiments, there are provided synthetic protein circuits wherein recruitment of synthetic protein circuit components to an association location upon activation of a signal transducer generates an active effector protein. The effector protein can be configured to carry out a variety of functions when in an active state, such as, for example, inducing cell death. Methods of treating a disease or disorder characterized by aberrant signaling are provided in some embodiments.
Opening claim text (preview).
What is claimed is: 1. A synthetic protein circuit, comprising: a first polypeptide comprising a first signal transducer binding domain and a first part of a first protease domain, wherein the first signal transducer binding domain is capable of binding a first signal transducer to form a first signal transducer-bound polypeptide; a second polypeptide comprising a second signal transducer binding domain and a second part of the first protease domain, wherein the second signal transducer binding domain is capable of binding a second signal transducer to form a second signal transducer-bound polypeptide, wherein the first part of the first protease domain and the second part of the first protease domain have weak association affinity, and wherein the first part of the first protease domain and the second part of the first protease domain are capable of associating with each other to constitute a first protease capable of being in a first protease active state when the first signal transducer and the second signal transducer are in close proximity at an association location; and an effector protein comprising a first cut site the first protease in the first protease active state is capable of cutting. 2. The synthetic protein circuit of claim 1 , wherein the first signal transducer binding domain of the first polypeptide and the second signal transducer binding domain of the second polypeptide are identical, and/or wherein the first signal transducer and the second signal transducer are identical. 3. The synthetic protein circuit of claim 1 , wherein the first signal transducer binding domain of the first polypeptide is capable of binding to the first signal transducer in a first signal transducer active state and/or wherein the second signal transducer binding domain of the second polypeptide is capable of binding to the second signal transducer in a second signal transducer active state, wherein the first signal transducer binding domain of the first polypeptide is capable of binding to the first signal transducer in a first signal transducer inactive state, and/or wherein the second signal transducer binding domain of the second polypeptide is capable of binding to the second signal transducer in a second signal transducer inactive state, wherein the signal transducer binding domain of the first polypeptide is capable of binding the first signal transducer to form the first signal transducer-bound polypeptide at the association location and/or wherein the signal transducer binding domain of the second polypeptide is capable of binding the second signal transducer to form the second signal transducer-bound polypeptide at the association location, and/or wherein the signal transducer binding domain of the first polypeptide is capable of binding the first signal transducer to form the first signal transducer-bound polypeptide at a first cellular location other than the association location, wherein the signal transducer binding domain of the second polypeptide is capable of binding the second signal transducer to form the second signal transducer-bound polypeptide at a second cellular location other than the association location, or both. 4. The synthetic protein circuit of claim 1 , wherein the first signal transducer, the second signal transducer, or both belong to a signal transduction pathway, wherein the first signal transducer, the second signal transducer, or both are endogenous proteins, wherein the first signal transducer and/or the second signal transducer are capable of regulating cell survival, cell growth, cell proliferation, cell adhesion, cell migration, cell metabolism, cell morphology, cell differentiation, apoptosis, or any combination thereof. 5. The synthetic protein circuit of claim 1 , wherein the first signal transducer, the second signal transducer, or both, are capable of being localized at the association location, wherein the first signal transducer when in a first signal transducer active state, the second signal transducer when in a second signal transducer active state, or both, are capable of being localized at the association location, and/or wherein the first signal transducer when in a first inactive state, the second signal transducer when in a second inactive state, or both, are capable of being localized at the association location. 6. The synthetic protein circuit of claim 1 , wherein the first part of the first protease domain and the second part of the first protease domain have the weak association affinity when the first signal transducer is in a first signal transducer inactive state and/or the second signal transducer inactive state, and/or wherein the first part of the first protease domain and the second part of the first protease domain are incapable of associating to form the first protease in the first protease active state when the first signal transducer is in a first signal transducer inactive state and/or the second signal transducer is in a second signal transducer inactive state. 7. The synthetic protein circuit of claim 1 , wherein the first part of the first protease domain and the second part of the first protease domain are capable of associating with each other to form the first protease in the first protease active state at a threshold first polypeptide concentration and a threshold second polypeptide concentration at the association location, wherein the threshold first polypeptide concentration and the threshold second polypeptide concentration at the association location are reached at a threshold signal transducer activation level of the first signal transducer and a threshold signal transducer activation level of the second signal transducer. 8. The synthetic protein circuit of claim 1 , wherein the effector protein is capable of changing a synthetic protein circuit component of the synthetic protein circuit to a synthetic protein circuit component active state. 9. The synthetic protein circuit of claim 1 , wherein the effector protein changes from an effector active state to an effector inactive state when the first protease in the first protease active state cuts the first cut site of the effector protein, wherein the effector protein in an effector active state is capable of activating or inactivating an endogenous signal transduction pathway, and/or wherein the effector protein in an effector active state is capable of inactivating an endogenous signal transduction pathway. 10. The synthetic protein circuit of claim 1 , wherein the effector protein changes from an effector inactive state to an effector active state when the first protease in the first protease active state cuts the first cut site of the effector. 11. The synthetic protein circuit of claim 10 , wherein a level of activation of the effector protein positively correlates with a first level of activation of the first signal transducer and/or a second level of activation of the second signal transducer, wherein the level of activation of the effector protein is related to a number of molecules of the effector protein in an effector active state, wherein the first level of activation of the first signal transducer is related to a number of molecules of the first signal transducer in a first transducer active state, and/or wherein the second level of activation of the second signal transducer is related to a number of molecules of the second signal transducer in a second transducer active state. 12. The synthetic protein circuit of claim 1 , wherein the effector protein changes from an effector active state to an effector inactive state when the first protease in the first protease active state cuts the first cut site of the effector protein, wherein a
Translation products from oncogenes · CPC title
General methods of protein analysis not limited to specific proteins or families of proteins · CPC title
Genes encoding for enzymes or proenzymes · CPC title
containing protease site · CPC title
Nuclear-inclusion-a endopeptidase (3.4.22.44) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.